Comprehensive evaluation of type 2 endotype and clinical features in patients with chronic rhinosinusitis with nasal polyps in Taiwan: a cross-sectional study
Authors:
- 13 July 2023
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (12) , 5379-5389
Abstract
Purpose Endotype-driven treatment has been introduced in the management of chronic rhinosinusitis with nasal polyps (CRSwNP), and an understanding of the associations between phenotypes and endotypes of CRSwNP will be beneficial in identifying responders. We aimed to determine the correlations between clinical manifestations and type 2 inflammatory mediators of sinonasal tissues. Methods Adult patients undergoing endoscopic sinus surgery for bilateral CRSwNP were prospectively enrolled. Tissue eosinophilia and type 2 mediator expression in tissue homogenates were assessed and correlated with clinical features, including symptoms, comorbidities, blood eosinophil counts, specific allergen immunoglobulin (IgE) testing, computed tomography (CT) scan findings, and Sino-Nasal Outcome Test-22 scores. Results A total of 93 subjects were recruited in our study. Fifty-nine (63.4%) cases were identified as the eosinophilic endotype, demonstrating with higher rates of comorbidity of asthma, blood eosinophilia and a high ethmoid-maxillary ratio on CT images. To correlate of phenotypes with the inflammatory mediator profile, multivariate analyses revealed the associations of IgE expression in nasal polyp tissues with allergen sensitization (p = 0.042), CT ethmoid-maxillary ratio (p = 0.001) and tissue eosinophil counts (p = 0.022); the association of interleukin (IL-5) expression with the blood eosinophil percentage (p = 0.020); and the association of IL-13 expression with white blood cell count (p = 0.002) and central compartment-type inflammation (p < 0.001). Conclusion We demonstrated associations of IgE and IL-5 expression with clinical features of eosinophilic-type inflammation and a significantly elevated level of IL-13 in patients with central-compartment-type CRSwNP. These observations may be useful when considering the use of type 2 biologic treatment and require further validation studies.Keywords
Funding Information
- National Science Council (#105-2314-B-002-032)
- National Taiwan University Hospital (#108-N4249)
This publication has 45 references indexed in Scilit:
- Disease-Specific T-Helper Cell Polarizing Function of Lesional Dendritic Cells in Different Types of Chronic Rhinosinusitis with Nasal PolypsAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Clinical characteristics and surrogate markers of eosinophilic chronic rhinosinusitis in Southern ChinaEuropean Archives of Oto-Rhino-Laryngology, 2014
- Damage‐associated molecular patterns stimulate interleukin‐33 expression in nasal polyp epithelial cellsInternational Forum of Allergy & Rhinology, 2013
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophiliaJournal of Allergy and Clinical Immunology, 2013
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialThe Lancet, 2012
- Eosinophilic Chronic Rhinosinusitis in JapanAllergology International, 2010
- Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult ChineseJournal of Allergy and Clinical Immunology, 2009
- Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus diseaseJournal of Allergy and Clinical Immunology, 2008
- Increased Communication Among Nasal Epithelial Cells in Air‐Liquid Interface CultureThe Laryngoscope, 2007
- Total and specific IgE in nasal polyps is related to local eosinophilic inflammationJournal of Allergy and Clinical Immunology, 2001